Amoxicillin/Clavulanate Potassium

阿莫西林/克拉维酸钾

Report date: 2026/05/26 20:00:28

Base Information

Drug NameAmoxicillin/Clavulanate Potassium
Drug Alias Name阿莫西林克拉维酸钾Amoxicillin Trihydrate/Clavulanate potassiumAmoxicillin/clavulanic acid modified releaseCo-amoxiclavamoxycillin/clavulanic acid +[7] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsLower Respiratory Tract InfectionsCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infections +[24] 
Global Approved IndicationsLower Respiratory Tract InfectionsAcute bacterial skin and skin structure infectionsOtitis Media +[7] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1981/04/03
Country/TerritoryCanadaUnited StatesBangladesh +[7] 
CombinationsYes Amoxicillin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDr.Reddy's Laboratories Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGeorgetown UniversityKaizen BioscienceUS Antibiotics LLC +[11] 
Inactive CompaniesGlaxosmithkline PlcStanford UniversityUniversity Of Oulu +[4] 
Active IndicationsLower Respiratory Tract InfectionsCommunity-acquired bacterial pneumoniaAcute bacterial skin and skin structure infections +[19] 
Inactive IndicationsWounds and InjuriesBites and StingsPyelonephritis +[5] 

Other Information

ATC CodeJ01CR02
Related LinksKEGG